Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Trends in Endocrinology   Volumes    Volume 14 
Evaluation of the relationship between C-reactive protein/lymphocyte count ratio and blood sugar regulation and other metabolic parameters in patients with type 2 diabetes mellitus
Tugrul Sagdic, Gulali Aktas
Pages: 11 - 23
Number of pages: 13
Current Trends in Endocrinology
Volume 14 

Copyright © 2023 Research Trends. All rights reserved

The C-reactive protein to lymphocyte ratio (CLR) has demonstrated associations with conditions characterized by persistent, mild inflammation. Given the inflammatory component of type 2 diabetes (T2DM), our aim was to explore the relationship between CLR and T2DM. T2DM patients attending internal medicine outpatient clinics were categorized into two groups based on their glycosylated hemoglobin (HbA1c) levels: well-controlled (HbA1c < 7%) and poorly controlled (HbA1c ≥ 7%) T2DM groups. Healthy individuals undergoing routine check-ups served as the control group. CLR levels were compared among the well-controlled and poorly controlled diabetic groups and the control group. The CLR levels in the T2DM group (3.51 (0.03-21.78)) were significantly higher than those in the control group (0.65 (0.02-2.92)) (p < 0.001). CLR exhibited a sensitivity of 63.2% and a specificity of 97.3% in predicting T2DM. Patients with poorly controlled diabetes had a CLR value of 4.76 (0.06-21.78), whereas those with well-controlled diabetes had a CLR value of 2.53 (0.03-12.07) (p < 0.001). The sensitivity and specificity of CLR in identifying poor diabetic control were 41.2% and 86.1%, respectively. The elevated CLR levels observed in T2DM patients, particularly in those with poorly controlled diabetes, suggest that CLR could serve as a valuable additional diagnostic tool in monitoring the treatment progress of T2DM patients.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms